amantadine has been researched along with Cerebral Palsy in 5 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case report describes a 15-year-old male patient with spastic diplegic cerebral palsy, Gross Motor Function Classification System Level III, who developed severe new cognitive and motoric impairments after the administration of haloperidol." | 7.79 | Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report. ( Gelfius, CD; Mortimer, D; Potts, MA, 2013) |
| "This case report describes a 15-year-old male patient with spastic diplegic cerebral palsy, Gross Motor Function Classification System Level III, who developed severe new cognitive and motoric impairments after the administration of haloperidol." | 3.79 | Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report. ( Gelfius, CD; Mortimer, D; Potts, MA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mortimer, D | 1 |
| Gelfius, CD | 1 |
| Potts, MA | 1 |
| Rohde, H | 1 |
| Mundinger, F | 1 |
| Milios, E | 1 |
| Mrozek, K | 1 |
| Kamińska, A | 1 |
| Marciniak, M | 1 |
| Lorizio, A | 1 |
| Ecari, U | 1 |
1 trial available for amantadine and Cerebral Palsy
| Article | Year |
|---|---|
[Results of clinical trials of the antispasmodic agent memantine].
Topics: Aged; Amantadine; Brain Injuries; Cerebral Palsy; Child; Child, Preschool; Clinical Trials as Topic; | 1982 |
4 other studies available for amantadine and Cerebral Palsy
| Article | Year |
|---|---|
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine | 2013 |
[Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
Topics: Adolescent; Adult; Aged; Amantadine; Athetosis; Basal Ganglia Diseases; Cerebral Palsy; Child; Chore | 1985 |
[Attempt at Larodopa and Viregyt treatment in a case of progressive supranuclear palsy].
Topics: Amantadine; Cerebral Palsy; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Middle Aged | 1972 |
[Clinical and electroencephalographic observations on the action of amantadine in the dystonic-athetosic disorders of infentile cerebral paralysis].
Topics: Adolescent; Amantadine; Athetosis; Brain; Cerebral Palsy; Child; Child, Preschool; Chorea; Electroen | 1971 |